Literature DB >> 25752548

Japanese universal health care faces a crisis in cancer treatment.

Yasuhiro Fujiwara1, Kan Yonemori2, Taro Shibata3, Natsuko Okita4, Nobuko Ushirozawa5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25752548     DOI： 10.1016/S1470-2045(15)70007-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

1.  Evolution of frameworks for expediting access to new drugs in Japan.

Authors:  Yasuhiro Fujiwara
Journal:  Nat Rev Drug Discov       Date:  2016-05-03       Impact factor: 84.694

2.  A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of Medicine.

Authors:  Akihiko Ozaki; Morihito Takita; Tetsuya Tanimoto
Journal:  Invest New Drugs       Date:  2018-03-08       Impact factor: 3.850

3.  Health insurance status and survival among patients with head and neck cancer in Japan.

Authors:  Yukinori Takenaka; Toshimichi Yasui; Keisuke Enomoto; Haruka Miyabe; Natsue Morizane; Naoki Ashida; Kotaro Shimizu; Masayuki Hirose; Yoshifumi Yamamoto; Atsuhiko Uno
Journal:  Int J Clin Oncol       Date:  2015-11-07       Impact factor: 3.402

Review 4.  Implementation of "clinical sequencing" in cancer genome medicine in Japan.

Authors:  Takashi Kohno
Journal:  Cancer Sci       Date:  2018-02-02       Impact factor: 6.716

5.  Advanced Medical Care Program for the Rapid Introduction of Healthcare Technologies to the National Health Insurance System in Japan.

Authors:  Keiko Ueda; Shoji Sanada; Naoto Uemura
Journal:  Clin Transl Sci       Date:  2020-02-27       Impact factor: 4.689

6.  Comparison of acute vertigo diagnosis and treatment practices between otolaryngologists and non-otolaryngologists: A multicenter scenario-based survey.

Authors:  Kenji Numata; Takashi Shiga; Kazuhiro Omura; Akiko Umibe; Eiji Hiraoka; Shunsuke Yamanaka; Hiroyuki Azuma; Yasuhiro Yamada; Daiki Kobayashi
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

7.  Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study.

Authors:  Kuniko Sunami; Hitoshi Ichikawa; Takashi Kubo; Mamoru Kato; Yutaka Fujiwara; Akihiko Shimomura; Takafumi Koyama; Hiroki Kakishima; Mayuko Kitami; Hiromichi Matsushita; Eisaku Furukawa; Daichi Narushima; Momoko Nagai; Hirokazu Taniguchi; Noriko Motoi; Shigeki Sekine; Akiko Maeshima; Taisuke Mori; Reiko Watanabe; Masayuki Yoshida; Akihiko Yoshida; Hiroshi Yoshida; Kaishi Satomi; Aoi Sukeda; Taiki Hashimoto; Toshio Shimizu; Satoru Iwasa; Kan Yonemori; Ken Kato; Chigusa Morizane; Chitose Ogawa; Noriko Tanabe; Kokichi Sugano; Nobuyoshi Hiraoka; Kenji Tamura; Teruhiko Yoshida; Yasuhiro Fujiwara; Atsushi Ochiai; Noboru Yamamoto; Takashi Kohno
Journal:  Cancer Sci       Date:  2019-04-02       Impact factor: 6.716

8.  Application of the New Process for Unapproved Drug Use: Dilemma of Universal Health Care Coverage in Japan.

Authors:  Satoshi Nishiwaki; Yuichi Ando
Journal:  J Glob Oncol       Date:  2019-11

Review 9.  Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China.

Authors:  Takaaki Mizuno; Yuki Katsuya; Jun Sato; Takafumi Koyama; Toshio Shimizu; Noboru Yamamoto
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.